Surprisingly, a patient with a high percentage of CLL-1 + CD34 + CD38 − cells presented no symptoms and had stable blood tests at the time of sampling but developed aggressive AML within 6 months [38]. The gene discussed is CLEC12A; the disease is acute myeloid leukemia.